These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 16741021

  • 1. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
    Jesmin S, Zaedi S, Yamaguchi N, Maeda S, Shimojo N, Masuzawa K, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):902-6. PubMed ID: 16741021
    [Abstract] [Full Text] [Related]

  • 2. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
    Jesmin S, Zaedi S, Maeda S, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):925-31. PubMed ID: 16741025
    [Abstract] [Full Text] [Related]

  • 3. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K, Jesmin S, Maeda S, Zaedi S, Shimojo N, Miyauchi T, Goto K.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [Abstract] [Full Text] [Related]

  • 4. Effects of dual endothelin receptor antagonist on antiapoptotic marker Bcl-2 expression in streptozotocin-induced diabetic rats.
    Jesmin S, Zaedi S, Yamaguchi N, Maeda S, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1034-9. PubMed ID: 16741044
    [Abstract] [Full Text] [Related]

  • 5. Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats.
    Miyauchi Y, Jesmin S, Sakai S, Kamiyama J, Shimojo N, Rahman A, Islam M, Zaedi S, Maeda S, Maruyama H, Mizutani T, Homma S, Aonuma K, Miyauchi T.
    Life Sci; 2014 Aug 28; 111(1-2):6-11. PubMed ID: 24953608
    [Abstract] [Full Text] [Related]

  • 6. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts.
    Jesmin S, Zaedi S, Shimojo N, Iemitsu M, Masuzawa K, Yamaguchi N, Mowa CN, Maeda S, Hattori Y, Miyauchi T.
    Am J Physiol Endocrinol Metab; 2007 Apr 28; 292(4):E1030-40. PubMed ID: 17148754
    [Abstract] [Full Text] [Related]

  • 7. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K, Goto K, Jesmin S, Maeda S, Miyauchi T, Kaji Y, Oshika T, Hori S.
    Curr Eye Res; 2006 Jan 28; 31(1):79-89. PubMed ID: 16421022
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat.
    Shirai M, Yamanaka M, Shiina H, Igawa M, Kawakami T, Ishii N, Lue TF, Fujime M, Dahiya R.
    Biochem Biophys Res Commun; 2006 Mar 17; 341(3):755-62. PubMed ID: 16455052
    [Abstract] [Full Text] [Related]

  • 9. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.
    Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M, Marra C, Nasti R, Marfella R, Cozzolino D, Indolfi C, Cotrufo M, Torella R, Salvatore T.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):827-34. PubMed ID: 16139132
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor in diabetes induced early retinal abnormalities.
    Cukiernik M, Hileeto D, Evans T, Mukherjee S, Downey D, Chakrabarti S.
    Diabetes Res Clin Pract; 2004 Sep 06; 65(3):197-208. PubMed ID: 15331199
    [Abstract] [Full Text] [Related]

  • 11. Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes.
    Zoja C, Cattaneo S, Fiordaliso F, Lionetti V, Zambelli V, Salio M, Corna D, Pagani C, Rottoli D, Bisighini C, Remuzzi G, Benigni A.
    Am J Physiol Renal Physiol; 2011 Nov 06; 301(5):F1114-23. PubMed ID: 21816757
    [Abstract] [Full Text] [Related]

  • 12. Effect of systemic insulin and angiotensin II receptor subtype-1 antagonist on endothelin-1 receptor subtype(s) regulation and binding in diabetic rat heart.
    Karam CN, Nuwayri-Salti N, Usta JA, Zwainy DS, Abrahamian RE, Al Jaroudi WA, Baasisri MJ, Abdallah SM, Bitar KM, Bikhazi AB.
    Endothelium; 2005 Nov 06; 12(5-6):225-31. PubMed ID: 16410221
    [Abstract] [Full Text] [Related]

  • 13. Changes of macrovascular endothelial ultrastructure and gene expression of endothelial nitric oxide synthase in diabetic rats.
    Lu YL, Hu SJ, Shen ZJ, Shao YC.
    Chin Med J (Engl); 2004 Aug 06; 117(8):1165-9. PubMed ID: 15361289
    [Abstract] [Full Text] [Related]

  • 14. [Expression of VEGF in kidney of diabetic rats].
    Chen ZJ, Yang YB, Huang SM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul 06; 38(4):633-6. PubMed ID: 17718428
    [Abstract] [Full Text] [Related]

  • 15. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors.
    Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S.
    J Mol Cell Cardiol; 2000 Sep 06; 32(9):1621-9. PubMed ID: 10966825
    [Abstract] [Full Text] [Related]

  • 16. Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats.
    Tong YC, Cheng JT.
    J Urol; 2007 Nov 06; 178(5):2203-7. PubMed ID: 17870109
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
    Kusari J, Zhou SX, Padillo E, Clarke KG, Gil DW.
    Invest Ophthalmol Vis Sci; 2010 Feb 06; 51(2):1044-51. PubMed ID: 19710406
    [Abstract] [Full Text] [Related]

  • 18. Changes of messenger RNAs encoding vascular endothelial growth factor and its receptors during the development and maintenance of caprine corpora lutea.
    Kawate N, Tsuji M, Tamada H, Inaba T, Sawada T.
    Mol Reprod Dev; 2003 Feb 06; 64(2):166-71. PubMed ID: 12506348
    [Abstract] [Full Text] [Related]

  • 19. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S, Li Y, Huang YJ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep 06; 27(9):1003-6. PubMed ID: 21906476
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Mitsuhashi J, Morikawa S, Shimizu K, Ezaki T, Yasuda Y, Hori S.
    Exp Eye Res; 2013 Jan 06; 106():64-73. PubMed ID: 23178551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.